Dr John Myburgh discusses a reanalysis by Levin and colleagues of the FEAST trial, which looked at the adverse effects of the administration of saline or albumin fluid bolus in resuscitation.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv